VAN TUYL CHRISTOPHER (Chief Legal Officer) sold 6.7% of their position (10.81K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $290.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/19/2025ACC: 0001764013-25-000163
Officer· Chief Legal Officer
Since Dec 2024
-10.81K
Net shares
Net seller
$290.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.53K
Price / share
$26.78
Trade value
$228.41K
% of position
5.3%
12/18/2025
160.74K→152.21K
Common Stock
Direct
Shares
−2.28K
Price / share
$27.38
Trade value
$62.54K
% of position
1.5%
12/18/2025
152.21K→149.93K
Total
Net shares
−10.81K
Net value
-$290.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2025 | S · Sale | −8.53K | $26.78 | $228.41K | 5.3% | 160.74K | 152.21K |
| Common Stock Direct | 12/18/2025 | S · Sale | −2.28K | $27.38 | $62.54K | 1.5% | 152.21K | 149.93K |
| Total | −10.81K | -$290.94K | ||||||
Derivative Transactions0
No derivative transactions reported